Fluoropyrimidine sensitivity of human MCF-7 breast cancer cells stably transfected with human uridine phosphorylase

被引:12
作者
Cuq, P
Rouquet, C
Evrard, A
Ciccolini, J
Vian, L
Cano, JP
机构
[1] Fac Pharm Montpellier, Lab Toxicol Medicament, F-34060 Montpellier 02, France
[2] Lab Toxicocinet & Pharmacocinet, F-13385 Marseille, France
关键词
uridine phosphorylase; breast cancer; 5-FU; 5 ' DFUR; cancer gene therapy;
D O I
10.1054/bjoc.2001.1833
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The relationship between uridine phosphorylase (UP) expression level in cancer cells and the tumour sensitivity to fluoropyrimidines is unclear. In this study, we found that UP overexpression by gene transfer, and the subsequent efficient metabolic activation of 5-fluorouracil (5-FU) by the ribonucleotide pathway, does not increase the fluoropyrimidine sensitivity of MCF-7 human cancer cells. (C) 2001 Cancer Research Campaign.
引用
收藏
页码:1677 / 1680
页数:4
相关论文
共 21 条
[1]   Thymidine phosphorylase: its role in sensitivity and resistance to anticancer drugs [J].
Ackland, SP ;
Peters, GJ .
DRUG RESISTANCE UPDATES, 1999, 2 (04) :205-214
[2]  
ARMSTRONG RD, 1980, CANCER RES, V40, P3333
[3]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[4]  
Ciccolini J, 2000, CLIN CANCER RES, V6, P1529
[5]   Increased cytotoxicity and bystander effect of 5-fluorouracil and 5′-deoxy-5-fluorouridine in human colorectal cancer cells transfected with thymidine phosphorylase [J].
Evrard, A ;
Cuq, P ;
Ciccolini, J ;
Vian, L ;
Cano, JP .
BRITISH JOURNAL OF CANCER, 1999, 80 (11) :1726-1733
[6]  
Evrard A, 1999, INT J CANCER, V80, P465, DOI 10.1002/(SICI)1097-0215(19990129)80:3<465::AID-IJC21>3.0.CO
[7]  
2-6
[8]   An in vitro nucleoside analog screening method for cancer gene therapy [J].
Evrard, A ;
Vian, L ;
Aubert, C ;
Cano, JP .
CELL BIOLOGY AND TOXICOLOGY, 1996, 12 (4-6) :345-350
[9]  
HARAGUCHI M, 1993, CANCER RES, V53, P5680
[10]   Augmentation of antitumor activity of 5′-deoxy-5-fluorouridine by thymosin fraction 5 in mouse bladder cancer cells in vitro and in vivo [J].
Ikemoto, S ;
Sugimura, K ;
Wada, S ;
Yasumoto, R ;
Yamamoto, K ;
Kishimoto, T .
CANCER LETTERS, 1999, 145 (1-2) :121-126